Innovation for Health - 15-16 April 2021
Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Dharminder Chahal

CEO and Founder, SkylineDx & Investment Manager, Van Herk Investments

Dharminder has an extensive network in the life science industry and holds a strong track record in direct involvement of complex corporate transactions. These include the sale of the stake of Van Herk Investments in Crucell to Johnson and Johnson, deVGen to Syngenta and Octoplus to Dr. Reddy’s. Indirectly, with Van Herk Investments as important shareholder, he was involved in the recent sale of Ablynx to Sanofi and the deal between Galapagos and Gillead. Furthermore, he is CEO and founder of SkylineDx, fund manager at Swanbridge Capital and active for several companies as board member or advisor.
Jan van de Winkel
Genmab
Eline Vrijland-van Beest
Hybridize Therapeutics

Carmen van Vilsteren
Topsector Life Science & Health

Tim Van Hauwermeiren 
argenx

Antoon van Oosterhout
Imyse SA
Willem Mulder
TU/E
Jolanda M. de Vries
Radboudumc
Yvette van Kooyk
Amsterdam UMC
Ronald Plasterk
Frame Cancer Therapeutics
Paul WG Elbers
Amsterdam UMC
Prof. Dr. Ing. Ron A.M. Fouchier
Erasmus MC
Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: www.innovationforhealth.nl/privacy-policy